These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 8148471

  • 1. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
    Baraldi PG, Garuti L, Leoni A, Cacciari B, Budriesi R, Chiarini A.
    Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
    [Abstract] [Full Text] [Related]

  • 2. 4-heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect.
    Rampa A, Chiarini A, Bisi A, Budriesi R, Valenti P.
    Arzneimittelforschung; 1991 Jul; 41(7):705-9. PubMed ID: 1772458
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
    Gasco AM, Fruttero R, Sorba G, Gasco A, Budriesi R, Chiarini A.
    Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057
    [Abstract] [Full Text] [Related]

  • 4. Fluorenone and benzophenone 1,4-dihydropyridine derivatives with cardiodepressant activity.
    Rampa A, Budriesi R, Bisi A, Chiarini A, Valenti P.
    Arzneimittelforschung; 1992 Nov; 42(11):1284-7. PubMed ID: 1492840
    [Abstract] [Full Text] [Related]

  • 5. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
    Budriesi R, Rampa A, Bisi A, Fabbri G, Chiarini A, Valenti P.
    Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and pharmacological characterization of some benzazepinone derivatives.
    Budriesi R, Rampa A, Bisi A, Fabbri G, Chiarini A, Valenti P.
    Arzneimittelforschung; 1995 Mar; 45(3):234-9. PubMed ID: 7741775
    [Abstract] [Full Text] [Related]

  • 7. Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.
    Budriesi R, Ioan P, Locatelli A, Cosconati S, Leoni A, Ugenti MP, Andreani A, Di Toro R, Bedini A, Spampinato S, Marinelli L, Novellino E, Chiarini A.
    J Med Chem; 2008 Mar 27; 51(6):1592-600. PubMed ID: 18303827
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M, Matowe WC, Akula MR, Vo D, Dagnino L, Li-Kwong-Ken MC, Wolowyk MW, Knaus EE.
    J Med Chem; 1998 Feb 12; 41(4):509-14. PubMed ID: 9484501
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T, Kase N, Kita H, Uematsu T.
    Arzneimittelforschung; 1986 Feb 12; 36(1):29-34. PubMed ID: 3754142
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and pharmacological profile of some chloroxanthone-1, 4-dihydropyridine derivatives.
    Bisi A, Budriesi R, Rampa A, Fabbri G, Chiarini A, Valenti P.
    Arzneimittelforschung; 1996 Sep 12; 46(9):848-51. PubMed ID: 8876931
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
    Iqbal N, Akula MR, Vo D, Matowe WC, McEwen CA, Wolowyk MW, Knaus EE.
    J Med Chem; 1998 May 21; 41(11):1827-37. PubMed ID: 9599233
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei C, Leonardi A, Testa R.
    Arzneimittelforschung; 1996 Jan 21; 46(1):15-24. PubMed ID: 8821512
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of 1,4-dihydropyridine calcium channel modulators having a diazen-1-ium-1,2-diolate nitric oxide donor moiety for the potential treatment of congestive heart failure.
    Velázquez C, Knaus EE.
    Bioorg Med Chem; 2004 Jul 15; 12(14):3831-40. PubMed ID: 15210150
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.